FDA Expert Panel Sparks Concern Over Misleading Information On Antidepressants During Pregnancy
A recent FDA panel discussion on the use of antidepressants during pregnancy has sparked concern among healthcare professionals and experts, who claim that the panel spread misinformation about the drugs’ safety. The panel, comprising mostly critics of antidepressant use, presented studies with flawed controls and made inaccurate statements about the risks associated with SSRIs. The … Read more